Condition 1: Pressure ulcer- Pressure ulcer- Nano wound dressing. Condition 2: Pressure ulcer. Condition 3: Pressure ulcer. Pressure ulcer of unspecified elbow, stage 2, stage 3 and Stage IV Pressure ulcer of unspecified elbow, stage 3 Pressure ulcer of unspecified elbow, stage 4
Conditions
Interventions
Intervention 1: Intervention group: Patients with pressure ulcers treated with the nano-smart wound dressing alongside standard wound care. Intervention 2: Control group: Patients with pressure ulcers
Sponsors
Pajoohesh BAMA Co.
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with pressure ulcers (decubitus ulcers/bedsores) Participants aged between 18 and 80 years Participants who are willing and able to comply with the use of the smart wound dressing Participants who provide signed written informed consent
Exclusion criteria
Exclusion criteria: Not applicable.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of wound infection or recurrence of necrosis. Timepoint: Days 3, 7, and 14. Method of measurement: A visual observation–based scoring system.;Intensity of pain. Timepoint: Days 3, 7, and 14. Method of measurement: Assessment by visual inspection.;The extent of changes in IL-6, TNF-a, CRP. Timepoint: Days 3, 7, and 14. Method of measurement: Biochemical analysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhazaleh Chizari Fard
Pajoohesh BAMA Co.
Outcome results
None listed